Grants

Grants & Other Sponsored Projects

 

We're working to update the sponsored projects information that appears on this page. Please check back!

Title Principal Investigator Unitsort descending Sponsor Name
A Two-Cohort, Open-Label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination with Tratuzumab and Vinor...
Stopeck,Alison T
Cancer Center Division
Genetech, Incorporated
Response of Human Prostate Tissue to Hypofractionated Ionizing Radiation
Sroka,Thomas C
Cancer Center Division
United States Army Medical Command
Phase II Trial of Vitamin D Supplementation in Individuals with Intermediate-Thickness Melanoma without Nodal Involvement
Jeter,Joanne M
Cancer Center Division
The Hope Foundation
Health-Related Quality-of-Life and Health-Care Resource Utilization Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies
Leischow,Scott J
Cancer Center Division
Nabi Biopharmaceuticals
Phase 3 Study of SGN-35 (brentuximab vedotin) and best supportive case (BSC)...residual Hodgkin Lymphoma (HL) following autologous stem cell...
Yeager,Andrew M
Cancer Center Division
Seattle Genetics, Incorporated
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy (Proclaim)
Jeter,Joanne M
Cancer Center Division
Prometheus Labs
New Combination Therapies for Advanced Prostate Cancer Based on the Radiosensitizing Potential of 5-Azacytidine
Weterings,Eric
Cancer Center Division
United States Army Medical Research and Material Command
Development of an Automated In Situ Test to Perform Molecular Sub-Classification of Prostate Cancer in Standard Prostate Biopsies
Sokoloff,Mitchell H
Cancer Center Division
Ventana Medical Systems, Inc.
Physical Activity Form Processing Support
Hamilton,Lynn A
Cancer Center Division
Science Applications International Corporation
Further Investigation of CFZ anti-tumor activity in SCLC in vitro and in vivo models
Garland,Linda L
Cancer Center Division
Onyx Pharmaceuticals
An Automated Karyometric Assay to Predict Response to Drugs that Reduce the Risk of Breast Cancer
Frank,Denise H
Cancer Center Division
Vala Sciences, Incorporated
Lymphoma Research Foundation Clinical Career Development Award
Schatz,Jonathan H
Cancer Center Division
Lymphoma Research Foundation
Molecular mechanisms of centrosome amplification in cancer cells
Rogers,Gregory C
Cancer Center Division
Arizona Biomedical Research Commission
Evaluating the Role of Mitochondrial ROS in SCC Cell Proliferation and Migration using Cybrid Model
Jandova,Jana
Cancer Center Division
Dermatology Foundation
Multi-Modality Imaging of Window Chambers
Gmitro,Arthur F
Cancer Center Division
Arizona Biomedical Research Commission
USC Consortium: Colon Cancer Family Registry
Lance,Michael P
Cancer Center Division
University of Southern California
Establishing an International Network and Regional Network of Healthcare Providers to Treat Tobacco Dependence
Leischow,Scott J
Cancer Center Division
Mayo Clinic
Public Health Surveillance of the Prevention of Complications of Bleeding and Clotting Disorders
Stopeck,Alison T
Cancer Center Division
University of Colorado
Phase III Colon Cancer Prevention Trial
Gerner,Eugene W
Cancer Center Division
University of California, Irvine
A Phase II/III, Multicenter, Partial Randomized, Open-Label Comparing prophylactic Treatment With BAY 94-9027 To On Demand Infusion
Stopeck,Alison T
Cancer Center Division
Bayer
Physical Activity Forms and Processing Support
Hamilton,Lynn A
Cancer Center Division
Science Applications International Corporation
Equipment and Training Grant
Iannone,Maria E
Cancer Center Division
The Hemophilia Alliance Foundation
A Randomised Multicenter, Phase III Open-Label Study of the Efficacy and Safety of Trastuzmab-MCC-DM1 vs. Capecitabine + Lapatinib in Patients with...
Stopeck,Alison T
Cancer Center Division
Genetech, Incorporated
An open label, multi-center, phase 3 study with corresponding blinded image to determine the efficacy and safety of a single intravenous injection ..
Kuo,Phillip H
Cancer Center Division
Bayer Healthcare Pharmaceuticals Incorportated
Development of folic acid derivatives for skin protection
Gandolfi,A Jay
Cancer Center Division
Niadyne, Incorporated
A Phase II Randomized, Double-blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide with or without Deforolimus...
Ahmann,Frederick R
Cancer Center Division
Merck and Company
Development of an Automated in situ Test to Perform Molecular Sub-classification of Prostate Cancer in Standard Prostate Biopsies
Stratton,Steven P
Cancer Center Division
Ventana Medical Systems, Inc.
Southwest Oncology Group Operations Office Grant
Krouse,Robert S
Cancer Center Division
University of Michigan
Molecular mechanisms of centrosome amplification in cancer cells
Rogers,Gregory C
Cancer Center Division
Arizona Biomedical Research Commission
A-LONG: An Open-label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant Factor VIII Fc Fusion Protein ...
Stopeck,Alison T
Cancer Center Division
Biogen Idec, Incorporated

Pages

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona